{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-044934","form_type":"8-K","ticker":"LAB","cik":"0001162194","company_name":"STANDARD BIOTOOLS INC.","filed_at":"2026-11-19T22:00:02+00:00","discovered_at":"2026-11-19T22:02:00.162345+00:00","generated_at":"2026-11-19T22:02:13.182480+00:00","sec_items":["5.02","5.07","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Standard BioTools holders approve Treeline merger, reverse split up to 1-for-40, Mass Cytometry sale","bullets":["All seven special-meeting proposals passed; share issuance for the Treeline Biosciences merger won 274,099,041 votes for vs 7,571,806 against.","Charter amendment approved to effect a reverse split of 1-for-20 to 1-for-40, ratio to be mutually agreed with Treeline, and rename the company Treeline Biosciences, Inc.","Element Mass Cytometry divestiture to Element Biosystems, LLC (a GMT Venture Partners vehicle) approved 276,299,544 to 5,336,020.","Quorum of 281,744,412 votes, about 71.38% of the 394,711,296 shares outstanding as of the October 16, 2026 record date; no broker non-votes.","Treeline merger expected to close in Q4 2026, with the Mass Cytometry sale closing substantially concurrently; CEO Michael Egholm called the votes an important step."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-044934","json":"https://secwatch.observer/filing/0001140361-26-044934.json","markdown":"https://secwatch.observer/filing/0001140361-26-044934.md","text":"https://secwatch.observer/filing/0001140361-26-044934.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1162194/000114036126044934/0001140361-26-044934-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1162194/000114036126044934/ef20085888_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-11-19T22:02:13.182480+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}